BLEECKER(EPA:BLEE) stock Fundamental Analysis

Fundamental Rating

Overall BLEE gets a fundamental rating of 2 out of 10. We evaluated BLEE against 43 industry peers in the Diversified REITs industry. Both the profitability and financial health of BLEE have multiple concerns. BLEE has a expensive valuation and it also scores bad on growth.

Quickly go to:

1. Profitability

1.1 Basic Checks

BLEE had negative earnings in the past year.

BLEE had a positive operating cash flow in the past year.

In multiple years BLEE reported negative net income over the last 5 years.

BLEE had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

With a Return On Assets value of -6.98%, BLEE is not doing good in the industry: 82.50% of the companies in the same industry are doing better.

With a Return On Equity value of -15.94%, BLEE is not doing good in the industry: 87.50% of the companies in the same industry are doing better.

BLEE has a worse Return On Invested Capital (1.50%) than 87.50% of its industry peers.

Measured over the past 3 years, the Average Return On Invested Capital for BLEE is below the industry average of 3.77%.

The 3 year average ROIC (0.99%) for BLEE is below the current ROIC(1.50%), indicating increased profibility in the last year.

		Industry Rank	Sector Rank
ROA	-6.98%
ROE	-15.94%
ROIC	1.5%

ROA(3y)-3.74%

ROA(5y)0.76%

ROE(3y)-8.73%

ROE(5y)0.96%

ROIC(3y)0.99%

ROIC(5y)0.83%

1.3 Margins

BLEE's Operating Margin of 38.10% is on the low side compared to the rest of the industry. BLEE is outperformed by 82.50% of its industry peers.

BLEE's Operating Margin has improved in the last couple of years.

BLEE has a worse Gross Margin (46.11%) than 82.50% of its industry peers.

In the last couple of years the Gross Margin of BLEE has grown nicely.

		Industry Rank	Sector Rank
OM	38.1%
PM (TTM)	N/A
GM	46.11%

OM growth 3Y30.72%

OM growth 5Y9.78%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y16.22%

GM growth 5Y5.35%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BLEE is destroying value.

BLEE has about the same amout of shares outstanding than it did 1 year ago.

Compared to 5 years ago, BLEE has about the same amount of shares outstanding.

Compared to 1 year ago, BLEE has an improved debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of 0.93, we must say that BLEE is in the distress zone and has some risk of bankruptcy.

BLEE has a Altman-Z score (0.93) which is in line with its industry peers.

BLEE has a debt to FCF ratio of 477.31. This is a negative value and a sign of low solvency as BLEE would need 477.31 years to pay back of all of its debts.

BLEE has a Debt to FCF ratio of 477.31. This is amonst the worse of the industry: BLEE underperforms 87.50% of its industry peers.

BLEE has a Debt/Equity ratio of 1.14. This is a high value indicating a heavy dependency on external financing.

Looking at the Debt to Equity ratio, with a value of 1.14, BLEE is doing worse than 85.00% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	1.14
Debt/FCF	477.31
Altman-Z	0.93

ROIC/WACC0.35

WACC4.28%

2.3 Liquidity

A Current Ratio of 0.87 indicates that BLEE may have some problems paying its short term obligations.

With a decent Current ratio value of 0.87, BLEE is doing good in the industry, outperforming 65.00% of the companies in the same industry.

BLEE has a Quick Ratio of 0.87. This is a bad value and indicates that BLEE is not financially healthy enough and could expect problems in meeting its short term obligations.

The Quick ratio of BLEE (0.87) is better than 67.50% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	0.87
Quick Ratio	0.87

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

BLEE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -58.73%.

BLEE shows a small growth in Revenue. In the last year, the Revenue has grown by 2.86%.

BLEE shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.33% yearly.

EPS 1Y (TTM)-58.73%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-18.84%

Revenue 1Y (TTM)2.86%

Revenue growth 3Y11.64%

Revenue growth 5Y7.33%

Sales Q2Q%2.1%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BLEE. In the last year negative earnings were reported.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of BLEE indicates a rather expensive valuation: BLEE more expensive than 87.50% of the companies listed in the same industry.

		Industry Rank	Sector Rank
P/FCF	221.53
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for BLEE!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

BLEECKER

EPA:BLEE (2/19/2025, 7:00:00 PM)

129

0 (0%)

Chartmill FA Rating

GICS SectorReal Estate

GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)

GICS IndustryDiversified REITs

Earnings (Last)N/A N/A

Earnings (Next)N/A N/A

Inst OwnersN/A

Inst Owner ChangeN/A

Ins Owners71.74%

Ins Owner ChangeN/A

Market Cap145.77M

AnalystsN/A

Price TargetN/A

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly Dividend41.2

Dividend Growth(5Y)N/A

DP0%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	4.87
P/FCF	221.53
P/OCF	18.07
P/B	0.56
P/tB	0.57
EV/EBITDA	N/A

EPS(TTM)-36.76

EYN/A

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)0.58

FCFY0.45%

OCF(TTM)7.14

OCFY5.53%

SpS26.51

BVpS229.43

TBVpS226.78

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-6.98%
ROE	-15.94%
ROCE	2.04%
ROIC	1.5%
ROICexc	1.51%
ROICexgc	1.52%
OM	38.1%
PM (TTM)	N/A
GM	46.11%
FCFM	2.2%

ROA(3y)-3.74%

ROA(5y)0.76%

ROE(3y)-8.73%

ROE(5y)0.96%

ROIC(3y)0.99%

ROIC(5y)0.83%

ROICexc(3y)0.99%

ROICexc(5y)0.84%

ROICexgc(3y)1%

ROICexgc(5y)0.84%

ROCE(3y)1.34%

ROCE(5y)1.13%

ROICexcg growth 3Y47.05%

ROICexcg growth 5Y20.23%

ROICexc growth 3Y47.05%

ROICexc growth 5Y20.22%

OM growth 3Y30.72%

OM growth 5Y9.78%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y16.22%

GM growth 5Y5.35%

F-Score5

Asset Turnover0.05

Health

		Industry Rank	Sector Rank
Debt/Equity	1.14
Debt/FCF	477.31
Debt/EBITDA	N/A
Cap/Depr	N/A
Cap/Sales	24.73%
Interest Coverage	0.79
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	0.87
Quick Ratio	0.87
Altman-Z	0.93

F-Score5

WACC4.28%

ROIC/WACC0.35

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)23.61%

Cap/Sales(5y)36.58%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-58.73%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-18.84%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)2.86%

Revenue growth 3Y11.64%

Revenue growth 5Y7.33%

Sales Q2Q%2.1%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y5.04%

EBIT growth 3Y45.94%

EBIT growth 5Y17.83%

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-85.47%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y55.4%

OCF growth 3Y120.64%

OCF growth 5Y3.91%

BLEECKER (BLEE.PA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens